Is neuropeptide Y a naturally occurring appetite transducer?

Current Opinion in Endocrinology and Diabetes

Volumn 3, Issue 2, 1996, Pages 157-163

  Kalra, Satya P ^a   Kalra, Pushpa S ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0000447329     PISSN: 10683097     EISSN: None     Source Type: Journal    
DOI: 10.1097/00060793-199604000-00014     Document Type: Article

References (76)

1. Anand BK, Brobeck JR: Hypothalamic control of food intake in rats and cats. Yale J Biol Med 1951, 24:123-140.
2. Kalra SP, Kalra PS: Neuropeptide Y: a novel peptidergic signal for the control of feeding behavior. In Current Topics in Neuroendocrinology, vol 10. Edited by Pfaff DW, Ganten D. Berlin: Springer-Verlag, 1990:192-217.
3. Morley JE: Neuropeptide regulation of appetite and weight. Endocr Rev 1987, 8:256-287.
4. Clark JT, Kalra PS, Crowley WR, Kalra SP: Neuropeptide Y and human pancreatic polypeptide stimulate feeding behavior in rats. Endocrinology 1984, 115:427-429.
5. Clark JT, Kalra PS, Crowley WR, Kalra SP: Neuropeptide Y stimulates feeding, but inhibits sexual behavior in rats. Endocrinology 1985, 117:2435-2442.
6. Kalra SP, Dube MG, Kalra PS: Continuous intraventricular infusion of neuropeptide Y evokes episodic food intake in satiated female rats: effects of adrenalectomy and cholecystokinin. Peptides 1988, 9:723-728.
7. Stanley BG, Kyrkouli SE, Lampert S, Leibowitz SF: Neuropeptide Y chronically injected into the hypothalamus: a powerful neurochemical inducer of hyperphagia and obesity. Peptides 1986, 7:1189-1192.
8. Zarjevski N, Cusin I, Vettor CR, Rohner-Jeanrenaud F, Jeanrenaud B: Chronic intracerebroventricular neuropeptide Y administration to normal rats mimics hormonal and metabolic changes of obesity. Endocrinology 1993, 133:1753-1758.
9. Vettor R, Zarjevski N, Cusin I, Rohner-Jeanrenaud F, Jeanrenaud B: Induction and reversibility of an obesity syndrome by intracerebroventricular neuropeptide Y administration to normal rats. Diabetologia 1994, 37:1202-1208.
10. Tatemoto K: Neuropeptide Y: complete amino acid sequence of the brain peptide. Proc Natl Acad Sci U S A 1982, 79:2514-2518.
11. Tatemoto K, Carlquist M, Mutt V: Neuropeptide Y: a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide. Nature 1982, 296:659-660.
12. Allen YS, Adrian TE, Allen JM, Tatemoto K, Crow TJ, Bloom SR, Polak JM: Neuropeptide Y distribution in the rat brain. Science 1983, 221:877-879.
13. Everitt BJ, Hökfelt T: The coexistence of neuropeptide Y with other peptides and amines in the central nervous system. In Neuropeptide Y. Edited by Mutt V, Füxe K, Hökfelt T, Lundberg JD. New York: Raven Press; 1989:61-72.
14. Chronwall BB: Anatomical distribution of NPY and NPY messenger RNA in rat brain. In Neuropeptide Y. Edited by Mutt V, Füxe K, Hökfelt T, Lundberg JD. New York: Raven Press; 1988:51-60.
15. Bai FL, Yamano M, Shiotani Y, Emson PC, Smith AD, Powell JF, Tahyama M: An arcuato-paraventricular and dorsomedial hypothalamic neuropeptide Y-containing system which lacks noradrenalin in the rat. Brain Res 1985, 331:172-175.
16. Holets VR, Hökfelt T, Rokaeus A, Terenius L, Goldstein M: Locus caeruleus neurons in the rat containing neuropeptide Y, tyrosine hydroxylase or galanin and their efferent projections to the spinal cord, cerebral cortex and hypothalamus. Neuroscience 1988, 24:893-906.
17. Sahu A, Dube MG, Kalra SP, Kalra PS: Bilateral neural transactions at the level of mesencephalon increased food intake and reduce latency to onset of feeding in response to neuropeptide Y. Peptides 1988, 9:1269-1273.
18. Sahu A, Kalra SP, Crowley WR, Kalra PS: Evidence that neuropeptide Y-containing neurons in the brain stem project into selected hypothalamic nuclei: implication in feeding behavior. Brain Res 1988, 457:376-378.
19. Stanley BG, Chin AS, Leibowitz SF: Feeding and drinking elicited by central injection of neuropeptide Y: evidence for hypothalamic site(s) of action. Brain Res Bull 1985, 14:521-524.
20. Li B-H, Xu B, Rowland NE, Kalra SP: C-fos expression in the rat brain following central administration of neuropeptide Y and the effects of food consumption. Brain Res 1994, 665:277-294. First description of immediate early gene expression in various brain sites in response to intraventricular administration of neuropeptide Y. The results document the presence of neuropeptide Y target cells in the paraventricular nucleus and surrounding sites implicated in stimulation of feeding in rats.
21. Xu B, Li B-H, Rowland NE, Kalra SP: Neuropeptide Y injection into the fourth cerebroventricle stimulates c-fos expression in the paraventricular nucleus and other nuclei in the forebrain: effects of food consumption. Brain Res 1995, 696:227-231.
22. Kalra SP, Dube MG, Fournier A, Kalra PS: Structure-function analysis of stimulation of food intake by neuropeptide Y: effects of receptor agonists. Physiol Behav 1991, 50:5-9.
23. Stanley BG, Magdalin W, Seirafi A, Nguyen MM, Leibowitz SF: Evidence for neuropeptide Y mediation of eating produced by food deprivation and for a variant of the Y1 receptor mediating this peptide's effect. Peptides 1992, 13:581-587.
24. Dube MG, Xu B, Crowley WR, Kalra PS, Kalra SP: Evidence that neuropeptide Y is a physiological signal for normal food intake. Brain Res 1994, 646:341-344.
25. Kalra SP, Dube MG, Sahu A, Phelps C, Kalra PS: Neuropeptide Y secretion increases in the paraventricular nucleus in association with increased appetite for food. Proc Natl Acad Sci U S A 1991, 88:10931-10935.
26. Dube MG, Sahu A, Kalra PS, Kalra SP: Neuropeptide Y release is elevated from the microdissected paraventricular nucleus of food-deprived rats: an in vitro study. Endocrinology 1992, 131:684-688.
27. Sahu A, Kalra PS, Kalra SP: Food deprivation and ingestion induced reciprocal changes in neuropeptide Y concentrations in the paraventricular nucleus. Peptides 1988, 9:83-86.
28. White JD, Kershaw M: Increased hypothalamic neuropeptide Y expression following food deprivation. Mol Cell Neurosci 1990, 1:41-48.
29. Sahu A, White JD, Kalra PS, Kalra SP: Hypothalamic neuropeptide Y gene expression in rats on scheduled feeding regimen. Mol Brain Res 1992, 15:15-18.
30. Akabayashi A, Wahlestedt C, Alexander JT, Leibowitz SF: Specific inhibition of endogenous neuropeptide Y synthesis in arcuate nucleus by antisense oligonucleotides suppresses feeding behavior and insulin secretion. Mol Brain Res 1994, 21:55-61.
31. Burlet A, Grouzmann E, Musse N, Fernette B, Nicolas JP, Burlet C: The immunological impairment of arcuate neuropeptide Y neurons by ricin A chain produces persistent decrease of food intake and body weight. Neuroscience 1995, 66:151-159.
32. Sahu A, Sninsky CA, Kalra PS, Kalra SP: Neuropeptide Y concentration in microdissected hypothalamic regions and in vitro release from the medial basal hypothalamus preoptic area of streptozotocin-diabetic rats with and without insulin substitution therapy. Endocrinology 1990, 126:192-198.
33. Sahu A, Sninsky CA, Phelps CP, Dube MG, Kalra PS, Kalra SP: Neuropeptide Y release from the paraventricular nucleus increases in association with hyperphagia in streptozotocin-induced diabetic rats. Endocrinology 1992, 131:2979-2985.
34. White JD, Olchowsky D, Kershaw M, Berelowitz M: Increased hypothalamic content of preproneuropeptide Y messenger ribonucleic acid in streptozotocin-diabetic rats. Endocrinology 1990, 126:765-772.
35. Dryden S, Pickavance L, Frankish HM, Williams G: Increased neuropeptide Y secretion in the hypothalamic paraventricular nucleus of obese (fa/fa) Zucker rats. Brain Res 1995, 690:185-188.
36. Dube MG, Kalra PS, Crowley WR, Kalra SP: Evidence of a physiological role for neuropeptide Y in ventromedial hypothalamic lesion-induced hyperphagia. Brain Res 1995, 690:275-278.
37. Sahu A, Kalra SP: Neuropeptidergic regulation of feeding behavior: neuropeptide Y. Trends Endocr Metab 1993, 4:217-224.
38. Ciofi P, Fallon JH, Croix D, Polak JM, Tramu G: Expression of neuropeptide Y precursor-immunoreactivity in the hypothalamic dopaminergic tubero-infundibular system during lactation in rodents. Endocrinology 1991, 128:823-824.
39. Malabu UH, Kilpatrick A, Ware M, Vernon RG, Williams G: Increased neuropeptide Y concentrations in specific hypothalamic regions of lactating rats: possible relationship to hyperphagia and adaptive changes in energy balance. Peptides 1994, 15:83-87.
40. Pelletier G, Tong Y: Lactation but not prolactin increases the levels of preproNPY mRNA in the rat arcuate nucleus. Mol Cell Neurosci 1992, 3:286-290.
41. Smith MS: Lactation alters neuropeptide Y and proopiomelanocortin gene expression in the arcuate nucleus in the rat. Endocrinology 1993, 133:1258-1265.
42. Brady LS, Smith MA, Gold PW, Herkenham M: Altered expression of hypothalamic neuropeptide mRNA's in food-restricted and food-deprived rats. Neuroendocrinology 1992, 52:441-447.
43. Wade GN, Schneider JE: Metabolic fuels and reproduction in female mammals. Neurosci Biobehav Rev 1992, 16:235-272.
44. Bonavera JJ, Dube MG, Kalra PS, Kalra SP: Anorectic effects of estrogen may be mediated by decreased neuropeptide Y release in the hypothalamic paraventricular nucleus. Endocrinology 1994, 134:2367-2370. This study documents that estrogen-induced anorexia and decrease in body weight may be due to a decrease in neuropeptide Y release selectively in the paraventricular nucleus.
45. Sar M, Sahu A, Crowley WR, Kalra SP: Localization of neuropeptide Y (NPY) immunoreactivity in estradiol concentrating cells in the hypothalamus. Endocrinology 1990, 127:2752-2756.
46. Grunfeld C, Feingold K: Metabolic disturbances and wasting in the acquired immunodeficiency syndrome. N Engl J Med 1992, 327:329-337.
47. Clark JT, Gist RS, Kalra SP, Kalra PS: α2-Adrenoceptor blockade attenuates feeding behavior induced by neuropeptide Y and epinephrine. Physiol Behav 1988, 43:417-422.
48. Pavia JM, Hastings JS, Morris MJ: Neuropeptide Y potentiation of potassium-induced noradrenalin release in the hypothalamic paraventricular nucleus of the rat in vivo. Brain Res 1995, 690:108-111.
49. Levine AS, Billington CJ: Opioids: are they regulators of feeding? Physiol Biochem Behav 1989, 575:209-219.
50. Horvath TL, Naftolin F, Kalra SP, Leranth C: Neuropeptide Y innervation of β-endorphin-containing cells in the rat mediobasal hypothalamus: a light- and electronmicroscopic double-immunostaining analysis. Endocrinology 1992, 131:2461-2467.
51. Kalra PS: Neuropeptide Y stimulates β-endorphin release in the basal hypothalamus: role of gonadal steroids. Brain Res 1995, 705:353-356.
52. Horvath TL, Kalra SP, Naftolin F, Leranth C: Morphological evidence for a galanin-opiate interaction in the rat mediobasal hypothalamus. J Neuroendocrinol 1995, 7:579-588.
53. Dube MG, Horvath TL, Leranth C, Kalra PS, Kalra SP: Naloxone reduced feeding evoked by intracerebroventricular galanin injection. Physiol Behav 1994, 56:811-813.
54. Akabayashi A, Watanabe Y, Wahlestedt C, McEwen BS, Paez X, Leibowitz SF: Hypothalamic neuropeptide Y, its gene expression and receptor activity: relation to circulating corticosterone in adrenalectomized rats. Brain Res 1994, 665:201-212.
55. Baker RA, Kerkenham M: Arcuate nucleus neurons that project to the hypothalamic paraventricular nucleus: neuropeptidergic identity and consequences of adrenalectomy on mRNA levels in the rat. J Comp Neurol 1995, 358:518-530.
56. Ponsalle P, Srivastava LS, Uht RM, White JD: Glucocorticoids are required for food deprivation-induced increases in hypothalamic neuropeptide Y expression. J Neuroendocrinol 1992, 4:585-591.
57. Larsen PJ, Jessop DS, Chowdrey HS, Lightman SL, Mikkelsen JD: Chronic administration of glucocorticoids directly upregulates preproneuropeptide Y and Y1-receptor mRNA levels in the arcuate nucleus of the rat. J Neuroendocrinol 1994, 6:153-159.
58. Füxe K, Wilkstrom AC, Okret S, Agnati LF, Harfstrand A, Yu A-Y, Granholm L, Soli M, Vale W, Gustaffson JA: Mapping of glucocorticoid receptor immunoreactive neurons in the rat tel- and diencephalon using a monoclonal antibody against rat liver glucocorticoid receptor. Endocrinology 1985, 117:1803-1812.
59. Sahu A, Dube MG, Phelps CP, Sninsky CA, Kalra PS, Kalra SP: Insulin and insulin-like growth factor-II suppress neuropeptide Y release from the nerve terminals in the paraventricular nucleus: a putative hypothalamic site for energy homeostasis. Endocrinology 1995, 136:5718-5724. Insulin inhibits food intake and decreases body weight gain. Analysis of the pattern of paraventricular nucleus neuropeptide Y release in vivo and in vitro in this paper shows that the site of insulin action resides at the level of paraventricular nucleus nerve terminals or at the interneurons in contact with neuropeptide Y nerve terminals. Because IGF-II was just as effective as insulin in decreasing neuropeptide Y release from the paraventricular nucleus, insulin's action may be mediated by hypothalamic IGF-II neuronal pathway in the paraventricular nucleus.
60. Lesniak MA, Hill JM, Kiess W, Rojeski M, Pert CB, Roth J: Receptors for insulin-like growth factors I and II: autoradiographic localization in rat brain and comparison to receptors for insulin. Endocrinology 1988, 123:2089-2099.
61. Baskin DG, Wilcox BJ, Figlewisz DP, Dorsa DM: Insulin and insulin-like growth factors in the CNS. Trends Neurosci 1988, 11:107-111.
62. Lauterio TJ, Marson L, Daughaday WH, Baile CA: Evidence for the role of insulin-like growth factor II (IGF-II) in the control of food intake. Physiol Behav 1987, 40:755-758.
63. Reinhardt RR, Bondy CA: Insulin-like growth factors cross the blood-brain barrier. Endocrinology 1994, 135:1753-1761.
64. Lauterio TJ, Aravich PF, Rotwein P: Divergent effects of insulin or insulin-like growth factor II gene expression in the rat hypothalamus. Endocrinology 1990, 126:392-398.
65. Ahmed I, Lauterio TJ: Intracerebroventricular injection of insulin or glucose alters insulin-like growth factor II (IGF-II) concentrations in specific hypothalamic nuclei. Brain Res 1992, 595:242-248.
66. Schwartz MW, Sipols AJ, Marks JL, Sanacora G, White JD, Scheurink A, Kahn SE, Baskin DG, Woods SC, Figlewicz DR, Porte D Jr: Inhibition of hypothalamic neuropeptide Y gene expression by insulin. Endocrinology 1992, 130:3608-3616.
67. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM: Positional cloning of the mouse obese gene and its human homologue. Nature 1994, 372:425-432. First report of cloning of the mouse obese gene (ob) gene. This finding led to isolation and characterization of OB protein, which is secreted in large amounts concomitant with increased adiposity.
68. Watanabe Y, Akabayashi A, McEwen BS: Adrenal steroid regulation of neuropeptide Y (NPY) mRNA: differences between dentate hilus and locus caeruleus and arcuate nucleus. Mol Brain Res 1995, 28:135-140.
69. Campfield LA, Smith FJ, Guisez Y, Devos R, Burn P: Recombinant mouse ob protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 1995, 269:546-549. This paper shows that intraventricular injection of leptin decreased food intake and body weight in genetically obese mice.
70. Halaas JL, Gajiwala KS, Maffei SL, Cohen BT, Chait D, Rabinowitz RL, Lallone SK, Burley SK, Friedman JM: Weight-reducing effects of the plasma protein encoded by the obese gene. Science 1995, 269:543-546.
71. Pelleymounter MA, Cullen MJ, Baker MB, Hecht R, Winters D, Boone T, Collins F: Effects of the obese gene product on body weight regulation in ob/ob mice. Science 1995, 269:540-543.
72. Stephens TW, Basinski M, Bristow PK, Bue-Vallenkey JM, Burgett SG, Cratt L, Hale J, Hoffman J, Hsiung H, Kriauciuna A, Mackeller W, Rosteck P Jr, Schoner B, Smith D, Tinsley FC, Zang X-Y, Heiman M: The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature 1995, 377:530-532. Because administration of OB protein (leptin) by peripheral and central routes decreased food intake and body weight in genetically obese and lean mice, this study was the first to show that leptin decreases neuropeptide Y gene expression and release from the hypothalamus, thereby providing evidence that, like insulin, leptin may act centrally via modulation of the hypothalamic neuropeptide Y system.
73. Murakami T, Shima K: Cloning of rat obese cDNA and its expression in obese rats. Biochem Biophys Res Commun 1995, 209:944-952.
74. DeVos P, Saladin R, Auwerx J, Staels B: Induction of ob gene expression by corticosteroids is accompanied by body weight loss and reduced food intake. J Biol Chem 1995, 270:15958-15961.
75. Saladin R, DeVos P, Guerro-Millo M, Leturque A, Girard J, Staels B, Auwerx J: Transient increase in obese gene expression after food intake or insulin administration. Nature 1995, 337:527-529.
76. Funabashi T, Shimamura I, Hiraoka H, Arai T, Masahiko T, Nakamura T, Nozaki S, Yamashita S, Tatemura K, Tokunaga K: Enhanced expression of rat obese (ob) gene in adipose tissues of ventromedial hypothalamus (VMH)-lesioned rats. Biochem Biophys Res Commun 1995, 211:469-475.